07:00 , Apr 5, 2004 |  BC Week In Review  |  Company News

Micromet AG, Arizeke Inc. deal

Micromet granted a non-exclusive global license covering its single-chain antibody (SCA) patent portfolio to Arizeke to develop and commercialize SCAs targeting the polymeric immunoglobulin receptor (pIgR) antigen. Arizeke develops pulmonary delivery technologies for protein therapeutics...
08:00 , Mar 29, 2004 |  BC Extra  |  Company News

Micromet, Arizeke antibody deal

Micromet (Munich, Germany) granted a non-exclusive global license for its single-chain antibody (SCA) patent portfolio to Arizeke (San Diego, Calif.) to develop and commercialize SCAs targeting the polymeric immunoglobulin receptor (pIgR) antigen. Arizeke is developing...
07:00 , Sep 22, 2003 |  BC Week In Review  |  Company News

Arizeke, Copernicus deal

Copernicus granted Arizeke an exclusive license to IP covering the development of therapeutics that bind to the polymeric immunoglobulin receptor (pIgR). pIgR is a cell surface protein expressed by epithelial cells in the gut and...